CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody
Migration announcement Please note: the Roche Tissue Diagnostics Reagent Catalog and the VENTANA Product Document Library websites have been migrated to the eLabDoc portal on Roche DiaLog ( This site will no longer be available after July 31, 2020.

Skip to Content

Skip over Generic Navigation

  • Select your country:
DIAGNOSTICS F. Hoffmann-La Roche Ltd

CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody

CONFIRM anti-Estrogen Receptor (ER) (SP1), Breast Carcinoma, 100x
Catalog Number:790-4325
Ordering Code:05278414001
Quantity:250 tests
Clone Name:SP1
Regulatory Status:IVD

This antibody is intended for in vitro diagnostic (IVD) use. Ventana Medical Systems, Inc. (Ventana) CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody is a rabbit monoclonal antibody (IgG) that is intended for laboratory use for the qualitative detection of estrogen receptor (ER) antigen in sections of formalin fixed, paraffin embedded tissue on a Ventana automated slide stainer with Ventana detection kits and ancillary reagents. This antibody has been optimally diluted for use with Ventana iVIEWTM DAB detection kit. Light microscopy is used to detect the staining of cell components. CONFIRM anti-ER (SP1) is directed against an epitope present on human ER alpha protein located in the nucleus of ER positive normal and neoplastic cells. CONFIRM anti- ER (SP1) is indicated as an aid in the management, prognosis, and prediction of therapy outcome of breast cancer. The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests. Prescription only.

Health Care Provider Notice
This website is intended for healthcare professionals only.

The content on this website is intended for healthcare professionals only. Information intended for the general public can be found on Please confirm that you are a medical professional before accessing the content of this website.

Yes, I hereby certify that I am a healthcare professional. Continue
Third-Party Link Disclosure
Disclosure for Links to Third-Party Websites

You are now leaving the Roche website. The site you are about to visit is operated by third-parties. The link to this site neither makes nor implies any representation or warranty for any products or services offered on a third-party site and is intended only to enable convenient access to the third-party site and for no other purpose.